Literature DB >> 20550951

Secretogranin III in human neuroendocrine tumours: a comparative immunohistochemical study with chromogranins A and B and secretogranin II.

Guida Maria Portela-Gomes1, Lars Grimelius, Mats Stridsberg.   

Abstract

BACKGROUND: Different epitopes of the granin family of proteins, chromogranin (Cg) A, CgB and secretogranin (Sg) II, have been demonstrated in normal human pancreas, gastrointestinal tract, adrenal medulla and in several neuroendocrine tumours (NETs). SgIII has been recently reported in endocrine pancreas. The aim of the present study was to examine the expression of SgIII in different NETs and compare it with the expression of CgA, CgB and SgII epitopes.
MATERIAL AND METHODS: Tissue specimens from 47 NETs were analyzed. Antibodies to CgA 250-284, CgB 244-255, SgII 172-186 (C-terminal secretoneurin) and SgIII 348-361 were used for immunostaining.
RESULTS: SgIII was expressed in 41 of 47 NETs. The expression of SgIII agreed well with that of CgA, CgB and SgII, with exceptions of phaeochromocytomas, where more CgB and SgII immunoreactive cells were observed and parathyroid adenomas, which were only stained by CgA. In rectal NETs more cells expressed SgIII than CgA.
CONCLUSIONS: This is the first report on SgIII expression in various NETs. A majority of tumours studied displayed SgIII immunostaining, which indicates a functional relationship with the other granins.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20550951     DOI: 10.1016/j.regpep.2010.06.002

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  11 in total

Review 1.  Immunohistochemical and biochemical studies with region-specific antibodies to chromogranins A and B and secretogranins II and III in neuroendocrine tumors.

Authors:  Guida M Portela-Gomes; Lars Grimelius; Mats Stridsberg
Journal:  Cell Mol Neurobiol       Date:  2010-11-03       Impact factor: 5.046

Review 2.  The extended granin family: structure, function, and biomedical implications.

Authors:  Alessandro Bartolomucci; Roberta Possenti; Sushil K Mahata; Reiner Fischer-Colbrie; Y Peng Loh; Stephen R J Salton
Journal:  Endocr Rev       Date:  2011-08-23       Impact factor: 19.871

3.  Tat-PTD-modified oncolytic adenovirus driven by the SCG3 promoter and ASH1 enhancer for neuroblastoma therapy.

Authors:  Chuan Jin; Di Yu; Matko Čančer; Berith Nilsson; Justyna Leja; Magnus Essand
Journal:  Hum Gene Ther       Date:  2013-08       Impact factor: 5.695

Review 4.  Ligandomics: a paradigm shift in biological drug discovery.

Authors:  Wei Li; Iok-Hou Pang; Mario Thiego F Pacheco; Hong Tian
Journal:  Drug Discov Today       Date:  2018-01-08       Impact factor: 7.851

5.  Comparative ligandomics implicates secretogranin III as a disease-restricted angiogenic factor in laser-induced choroidal neovascularization.

Authors:  Liyang Ji; Prabuddha Waduge; Wencui Wan; Hong Tian; Jin Li; Jinsong Zhang; Rui Chen; Wei Li
Journal:  FEBS J       Date:  2022-02-01       Impact factor: 5.622

6.  Differential Expression of Secretogranins II and III in Canine Adrenal Chromaffin Cells and Pheochromocytomas.

Authors:  Hiroshi Gomi; Takahiro Nagumo; Kazushi Asano; Makoto Konosu; Tadashi Yasui; Seiji Torii; Masahiro Hosaka
Journal:  J Histochem Cytochem       Date:  2022-04-09       Impact factor: 4.137

7.  Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy.

Authors:  Michelle E LeBlanc; Weiwen Wang; Xiuping Chen; Nora B Caberoy; Feiye Guo; Chen Shen; Yanli Ji; Hong Tian; Hui Wang; Rui Chen; Wei Li
Journal:  J Exp Med       Date:  2017-03-22       Impact factor: 14.307

8.  SCG3 Protein Expression in Glioma Associates With less Malignancy and Favorable Clinical Outcomes.

Authors:  Yi Wang; Nan Ji; Junmei Wang; Jingli Cao; Deling Li; Yang Zhang; Liwei Zhang
Journal:  Pathol Oncol Res       Date:  2021-02-26       Impact factor: 3.201

9.  Mass spectrometry identification of granins and other proteins secreted by neuroblastoma cells.

Authors:  Wojciech Rozek; Malgorzata Kwasnik; Janusz Debski; Jan F Zmudzinski
Journal:  Tumour Biol       Date:  2013-03-22

10.  A Genomic Alternative to Identify Medullary Thyroid Cancer Preoperatively in Thyroid Nodules with Indeterminate Cytology.

Authors:  Richard T Kloos; Robert J Monroe; S Thomas Traweek; Richard B Lanman; Giulia C Kennedy
Journal:  Thyroid       Date:  2016-04-22       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.